John Park
Impact in
- Genetics top 0.5%
- Glioma Diagnosis and Treatment
- Internal Medicine top 1%
Papers in
- Co-authors
- Slawomir J. Marecik (50 shared papers)Leela M. Prasad (36 shared papers)Howard Alan Fine (2 shared papers)Nancy Garren (1 shared paper)Megan A. Mackey (1 shared paper)Kevin A. Camphausen (1 shared paper)Paul Duic (1 shared paper)Lyndon Kim (1 shared paper)
- Journals
- Diseases of the Colon & Rectum (14 papers)The American Surgeon (9 papers)World Journal of Surgery (3 papers)Breast Cancer Research and Treatment (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
John Park
206 papers receiving 10.4k citations
John Park's Hit Papers
Peers
Comparison fields: 5 of 207
- Genetics 1.2k
- Internal Medicine 364
- Oncology 2.4k
- Experimental and Cognitive Psychology 873
- Cancer Research 626
Countries citing papers authored by John Park
This map shows the geographic impact of John Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Park more than expected).
Fields of papers citing papers by John Park
This network shows the impact of papers produced by John Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Park. The network helps show where John Park may publish in the future.
Co-authors
The 25 scholars most cited alongside John Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma Hit paper breakdown → | 2008 | 1347 |
| 2 | Challenges in Representation Learning: A Report on Three Machine Learning Contests Hit paper breakdown → | 2013 | 1144 |
| 3 | Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab Hit paper breakdown → | 2016 | 686 |
| 4 | Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis Hit paper breakdown → | 2018 | 550 |
| 5 | A specific antidote for dabigatran: functional and structural characterization Hit paper breakdown → | 2013 | 464 |
| 6 | 2005 | 416 | |
| 7 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 8 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 9 | 2007 | 244 | |
| 10 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 11 | 1961 | 195 | |
| 12 | 2013 | 193 | |
| 13 | 2009 | 182 | |
| 14 | 2010 | 162 | |
| 15 | Connecting Informal and Formal Learning Experiences in the Age of Participatory Media | 2008 | 157 |
| 16 | 1999 | 153 | |
| 17 | Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. | 2000 | 147 |
| 18 | 2001 | 134 | |
| 19 | 2004 | 133 | |
| 20 | 2010 | 128 |
About John Park
John Park is a scholar working on Oncology, Surgery, Cardiology and Cardiovascular Medicine, Ophthalmology and Molecular Biology, having authored 224 papers that have together received 10.8k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (26 papers), Anorectal Disease Treatments and Outcomes (10 papers), Diverticular Disease and Complications (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Pain Mechanisms and Treatments (6 papers), Colorectal Cancer Screening and Detection (6 papers), Ocular Oncology and Treatments (6 papers) and Colorectal and Anal Carcinomas (5 papers). The work is most often cited by research in Genetics (1.2k citations), Internal Medicine (364 citations), Oncology (2.4k citations), Experimental and Cognitive Psychology (873 citations) and Cancer Research (626 citations). John Park has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Slawomir J. Marecik, Leela M. Prasad, Howard Alan Fine, Nancy Garren, Megan A. Mackey, Kevin A. Camphausen, Paul Duic, Lyndon Kim, Teri Nguyen Kreisl and John A. Butman. Their work appears in journals such as Diseases of the Colon & Rectum, The American Surgeon, World Journal of Surgery, Breast Cancer Research and Treatment and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.